Rezolute, Inc. (RZLT) Cash Flow Statement

NASDAQ: RZLTOperating cash, capex, free cash flow and buybacks.

Where RZLT’s cash came from and went, FY2026

June 30, 2026 · U.S. dollars
Cash from operations
−$64.6M
Capital expenditures
$0
Free cash flow
−$64.6M
Returned to shareholders
—
Change in cash
−$83.5M
cash at year-end $10.6M
Drawn from cash: $83.5MDrawn from cash$83.5MOther financing: $2.2MOther financing$2.2MCash used in operations: $64.6MCash used in operations$64.6M · 75%Acquisitions & other: $21.1MAcquisitions & other$21.1M · 25%$85.7M
Cash from operations
−$64.6M
Acquisitions & other
−$21.1M
Other financing
+$2.2M
Change in cash
−$83.5M

Drawn to scale: where the cash came from and how it was used. Hover for values.

RZLT operating cash flow, capex and free cash flow

Operating cash flowCapital expendituresFree cash flowFCF margin (right axis)

RZLT cash flow trends, FY2017–FY2026

Rezolute, Inc. cash flow trends
MetricTrendThenLatestChange
Operating cash flow−$13.3MFY2017−$64.6MFY2026—
Capital expenditures$407,929FY2017$0FY2026−100.0%
Free cash flow−$13.7MFY2017−$64.6MFY2026—
Stock-based compensation$6.0MFY2017$14.5MFY2026+10.3%/yr
Share buybacks (net)$0FY2017$0FY2022—

Change is the average annual growth (CAGR) or the difference between the first and latest year.

RZLT cash flow by activity

OperatingInvestingFinancingChange in cash

RZLT net income vs operating cash flow

Net incomeOperating cash flow

Operating cash flow above net income usually means earnings are backed by cash (depreciation and stock-based pay are non-cash expenses).

RZLT cash flow statement

Rezolute, Inc. annual cash flow statement
FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Operating activities
Net income−$77.6M−$74.4M−$68.5M−$51.8M−$41.1M−$20.9M−$20.3M−$30.4M−$29.9M−$20.3M
Depreciation & amortization$31,000$31,000$36,000$30,000$13,000$13,000$18,000$49,000$1.1M$1.1M
Stock-based compensation$14.5M$7.1M$7.4M$7.3M$3.7M$4.0M$3.3M$2.6M$5.1M$6.0M
Change in working capital$330,000$47,000$3.1M$1.0M−$642,000−$2.1M−$7.5M$8.4M$1.0M−$155,364
Other non-cash items−$1.9M−$1.9M$595,000−$1.0M−$1.6M−$1.4M$324,000$4.1M$8.6M$1,197
Cash from operating activities−$64.6M−$69.1M−$57.4M−$44.5M−$39.6M−$20.4M−$24.2M−$15.3M−$14.1M−$13.3M
Investing activities
Capital expenditures$0$0$0−$153,000−$153,000−$153,000−$153,000−$47,000−$5,816−$407,929
Investments (net)—−$14.5M$48.7M−$101.5M−$101.3M−$101.3M−$101.3M$231,000$1.7M−$195,383
Acquisitions & other investing−$21.1M$0$0$153,000$0$0$0$47,000$6,132$407,929
Cash from investing activities−$21.1M−$14.5M$48.7M−$101.5M−$101.5M−$101.5M−$101.5M$231,000$1.7M−$195,383
Financing activities
Share repurchases & issuance (net)————$179.8M————$14.6M
Net borrowing (repayment)———$0−$16.3M$15.0M$15.0M$15.0M$5.3M−$23,128
Shares issued$0$86.4M$49.0M$12.3M$122.8M$41.0M$24.1M$25.0M$0$0
Other financing$2.2M$20.9M$14.0M−$759,000−$137.3M−$4.5M−$16.5M−$15.0M$4.2M−$683,194
Cash from financing activities$2.2M$107.3M$63.0M$11.6M$149.0M$51.5M$22.6M$25.0M$9.5M$13.9M
Summary
Net change in cash−$83.5M$23.7M$54.4M−$134.4M$109.4M$31.1M−$1.6M$9.9M−$2.8M$424,525
Cash at end of period$10.6M$94.1M$70.4M$16.0M$150.4M$41.0M$10.0M$11.6M$1.6M$4.5M
Free cash flow−$64.6M−$69.1M−$57.4M−$44.6M−$39.6M−$20.4M−$24.2M−$15.4M−$14.1M−$13.7M

Negative numbers are cash paid out. Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported; data from EODHD.

RZLT cash generation

In fiscal 2026 (ended June 30, 2026), Rezolute generated -$64.6 million of cash from operations and spent $0 on capital expenditures, leaving free cash flow of -$64.6 million. Cash and equivalents fell by $83.5 million over the year.

Related: RZLT income statement, RZLT balance sheet. See the RZLT stock overview for the latest quote and news.

RZLT cash flow FAQ

What is Rezolute's free cash flow?

Rezolute's free cash flow was -$64.6 million in fiscal 2026: -$64.6 million of operating cash flow minus $0 of capital expenditures It was -$69.1 million a year earlier..

How much cash does Rezolute generate from operations?

Rezolute generated -$64.6 million of cash from operating activities in fiscal 2026.

Biotechnology: cash flow